A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Prostate Cancer
Ovarian Cancer
Renal Cell Carcinoma
Colorectal Carcinoma
Pancreatic Carcinoma
Non-small Cell Lung Carcinoma
Solid Tumors
Breast Cancer

Interventions

DRUG: Pegilodecakin
DRUG: Paclitaxel or Docetaxel and Carboplatin or Cisplatin
DRUG: FOLFOX (Oxaliplatin/Leucovorin/5-Fluorouracil)
DRUG: gemcitabine/nab-paclitaxel
DRUG: Capecitabine
DRUG: Pazopanib
DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: nivolumab
DRUG: Gemcitabine/carboplatin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]